INS and congenital isolated hyperinsulinism: The introduction of 18F-DOPA PET/CT to discriminate between focal and diffuse CHI has had a major impact on the clinical approach by obviating more invasive diagnostic procedures, such as selective arterial calcium stimulation with simultaneous venous sampling or transhepatic portal venous insulin sampling, and by optimizing surgical treatment because of increased diagnostic accuracy.